Insider transactions

EDGAR

Natera, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-16.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
546 transactions, 1,451,822 shares
Sum of shares × price per share: 365,591,600.4009

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 653

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2029-06-23 Filed 2020-06-25Brophy Michael Burkes Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (12,500)
Disposed (D)12,5000—37,500Direct (D) Not on this form version
F2, F7
  • F2 Each RSU represents a contingent right to receive one share of the common stock of the issuer.
  • F7 On March 22, 2019, the Reporting Person was granted RSUs covering 100,000 shares of common stock, which vests in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. On June 23, 2020, the criteria was satisfied for the vesting of RSUs covering 12,500 shares of common stock.
Open filing 0001179110-20-007780 Read from the filing’s XML Dispute this row
2029-06-08 Filed 2020-06-10Brophy Michael Burkes Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Units — underlying Common Stock (25,000)
Disposed (D)25,0000—50,000Direct (D) Not on this form version
F2, F6
  • F2 Each RSU represents a contingent right to receive one share of the common stock of the issuer.
  • F6 On March 22, 2019, the Reporting Person was granted RSUs covering 100,000 shares of common stock, which vests in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price, based on the average closing price per share of the Issuer's common stock for a calendar month, calculated as of the last day of such calendar month. On June 8, 2020, the criteria was satisfied for the vesting of RSUs covering 25,000 shares of common stock.
Open filing 0001179110-20-007206 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40315.26
12,610.4

Derived: shares × price per share. Exact value 12610.40.

8,210Indirect (I) by Caraluna 1 TrustYes
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)85316.9256
26,938.676

Derived: shares × price per share. Exact value 26938.6760.

8,125Indirect (I) By Caraluna 1 TrustYes
F1, F3, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.4100 to $317.4050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)145317.8748
46,091.846

Derived: shares × price per share. Exact value 46091.8460.

7,980Indirect (I) By Caraluna 1 TrustYes
F1, F4, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.56 to $318.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)240319.7733
76,745.592

Derived: shares × price per share. Exact value 76745.5920.

7,740Indirect (I) By Caraluna 1 TrustYes
F1, F5, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.8350 to $319.5250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)160320.0188
51,203.008

Derived: shares × price per share. Exact value 51203.0080.

7,580Indirect (I) By Caraluna 1 TrustYes
F1, F6, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.87 to $320.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40322
12,880

Derived: shares × price per share. Exact value 12880.

7,540Indirect (I) By Caraluna 1 TrustYes
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40323.0650
12,922.6

Derived: shares × price per share. Exact value 12922.6000.

7,500Indirect (I) By Caraluna 1 TrustYes
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40315.28
12,611.2

Derived: shares × price per share. Exact value 12611.20.

8,210Indirect (I) By Caraluna 2 TrustYes
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)48317.3253
15,231.6144

Derived: shares × price per share. Exact value 15231.6144.

8,162Indirect (I) By Caraluna 2 TrustYes
F1, F7, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.5200 to $317.4050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)182317.9626
57,869.1932

Derived: shares × price per share. Exact value 57869.1932.

7,980Indirect (I) By Caraluna 2 TrustYes
F1, F8, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.56 to $318.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)240319.2167
76,612.008

Derived: shares × price per share. Exact value 76612.0080.

7,740Indirect (I) By Caraluna 2 TrustYes
F1, F9, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.8350 to $319.5500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)120320.0683
38,408.196

Derived: shares × price per share. Exact value 38408.1960.

7,620Indirect (I) By Caraluna 2 TrustYes
F1, F10, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F10 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.9450 to $320.2600 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)80322.8750
25,830

Derived: shares × price per share. Exact value 25830.0000.

7,540Indirect (I) By Caraluna 2 TrustYes
F1, F11, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.62 to $323.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40324.76
12,990.4

Derived: shares × price per share. Exact value 12990.40.

7,500Indirect (I) By Caraluna 2 TrustYes
F1, F2
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  • F2 Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
Open filing 0001646649-26-000045 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)15304.5713
4,568.5695

Derived: shares × price per share. Exact value 4568.5695.

217,597Direct (D) Yes
F1, F2, F3
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $304.24 to $304.95 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • F3 Includes 38 shares acquired under the Issuer's 2015 Employee Stock Purchase Plan on October 31, 2026
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)51305.7527
15,593.3877

Derived: shares × price per share. Exact value 15593.3877.

217,546Direct (D) Yes
F1, F4
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.30 to $306.24 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)21306.4633
6,435.7293

Derived: shares × price per share. Exact value 6435.7293.

217,525Direct (D) Yes
F1, F5
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $306.39 to $306.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)50308.1980
15,409.9

Derived: shares × price per share. Exact value 15409.9000.

217,475Direct (D) Yes
F1, F6
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F6 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $307.70 to $308.54 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)64309.0817
19,781.2288

Derived: shares × price per share. Exact value 19781.2288.

217,411Direct (D) Yes
F1, F7
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F7 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $308.7200 to $309.6450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)110310.1655
34,118.205

Derived: shares × price per share. Exact value 34118.2050.

217,301Direct (D) Yes
F1, F8
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F8 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $309.81 to $310.66 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)100311.3116
31,131.16

Derived: shares × price per share. Exact value 31131.1600.

217,201Direct (D) Yes
F1, F9
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F9 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $310.99 to $311.98 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)106312.1965
33,092.829

Derived: shares × price per share. Exact value 33092.8290.

217,095Direct (D) Yes
F1, F10
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F10 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $312.00 to $312.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)74313.3168
23,185.4432

Derived: shares × price per share. Exact value 23185.4432.

217,021Direct (D) Yes
F1, F11
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F11 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $313.01 to $314.00 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)108314.7084
33,988.5072

Derived: shares × price per share. Exact value 33988.5072.

216,913Direct (D) Yes
F1, F12
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F12 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $314.04 to $315.01 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)169315.4827
53,316.5763

Derived: shares × price per share. Exact value 53316.5763.

216,744Direct (D) Yes
F1, F13
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F13 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $315.0900 to $316.0750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,838316.8674
582,402.2812

Derived: shares × price per share. Exact value 582402.2812.

214,906Direct (D) Yes
F1, F14
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F14 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.24 to $317.14 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)56318.1661
17,817.3016

Derived: shares × price per share. Exact value 17817.3016.

214,850Direct (D) Yes
F1, F15
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F15 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.36 to $318.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)105319.2993
33,526.4265

Derived: shares × price per share. Exact value 33526.4265.

214,745Direct (D) Yes
F1, F16
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F16 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.67 to $319.66 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)131320.0673
41,928.8163

Derived: shares × price per share. Exact value 41928.8163.

214,614Direct (D) Yes
F1, F17
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F17 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.67 to $320.54 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)51321.1191
16,377.0741

Derived: shares × price per share. Exact value 16377.0741.

214,563Direct (D) Yes
F1, F18
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F18 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $320.77 to $321.63 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)16321.85
5,149.6

Derived: shares × price per share. Exact value 5149.60.

214,547Direct (D) Yes
F1
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40323.8590
12,954.36

Derived: shares × price per share. Exact value 12954.3600.

214,507Direct (D) Yes
F1, F19
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F19 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.3800 to $324.3550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-10Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)45325.0509
14,627.2905

Derived: shares × price per share. Exact value 14627.2905.

214,462Direct (D) Yes
F1, F20
  • F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  • F20 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.56 to $325.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001646649-26-000044 Read from the filing’s XML Dispute this row
2026-11-03 Filed 2026-11-04Brophy Michael Burkes Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)470391.49
184,000.3

Derived: shares × price per share. Exact value 184000.30.

45,779Direct (D) Yes
F2
  • F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2025, as modified on September 10, 2025.
Open filing 0001697362-26-000024 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Fesko John Officer: PRESIDENT, CHIEF BUS. OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7388.2001
2,717.4007

Derived: shares × price per share. Exact value 2717.4007.

195,571Direct (D) Yes
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Open filing 0002010135-26-000028 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Fesko John Officer: PRESIDENT, CHIEF BUS. OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)295400.2942
118,086.789

Derived: shares × price per share. Exact value 118086.7890.

195,276Direct (D) Yes
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Open filing 0002010135-26-000028 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Rabinowitz Matthew Director · Officer: EXECUTIVE CHAIRMAN
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)17388.20
6,599.4

Derived: shares × price per share. Exact value 6599.40.

2,117,659Direct (D) Yes
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Open filing 0001646382-26-000029 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Rabinowitz Matthew Director · Officer: EXECUTIVE CHAIRMAN
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)731400.2942
292,615.0602

Derived: shares × price per share. Exact value 292615.0602.

2,116,928Direct (D) Yes
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Open filing 0001646382-26-000029 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3388.20
1,164.6

Derived: shares × price per share. Exact value 1164.60.

217,683Direct (D) Yes
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Open filing 0001646649-26-000043 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Sheena Jonathan Director · Other: CO-FOUNDER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)109400.2942
43,632.0678

Derived: shares × price per share. Exact value 43632.0678.

217,574Direct (D) Yes
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Open filing 0001646649-26-000043 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Brophy Michael Burkes Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8388.0301
3,104.2408

Derived: shares × price per share. Exact value 3104.2408.

46,566Direct (D) Yes
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs) and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Open filing 0001697362-26-000024 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Brophy Michael Burkes Officer: CHIEF FINANCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)317400.2942
126,893.2614

Derived: shares × price per share. Exact value 126893.2614.

46,249Direct (D) Yes
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units (RSUs) and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Open filing 0001697362-26-000024 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04RABINOWITZ DANIEL Officer: SEC. AND CHIEF LEGAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7388.20
2,717.4

Derived: shares × price per share. Exact value 2717.40.

168,214Direct (D) Yes
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Open filing 0001857843-26-000033 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04RABINOWITZ DANIEL Officer: SEC. AND CHIEF LEGAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)334400.2942
133,698.2628

Derived: shares × price per share. Exact value 133698.2628.

167,880Direct (D) Yes
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Open filing 0001857843-26-000033 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Moshkevich Solomon Officer: PRESIDENT, CLINICALDIAGNOSTICS
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)9388.2001
3,493.8009

Derived: shares × price per share. Exact value 3493.8009.

104,733Direct (D) Yes
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Open filing 0002010019-26-000038 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Moshkevich Solomon Officer: PRESIDENT, CLINICALDIAGNOSTICS
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)410400.2942
164,120.622

Derived: shares × price per share. Exact value 164120.6220.

104,323Direct (D) Yes
F1
  • F1 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 31, 2025.
Open filing 0002010019-26-000038 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Moshkevich Solomon Officer: PRESIDENT, CLINICALDIAGNOSTICS
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)200405.2560
81,051.2

Derived: shares × price per share. Exact value 81051.2000.

104,123Direct (D) Yes
F2, F3
  • F2 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.
  • F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $404.8500 to $405.8450 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0002010019-26-000038 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Moshkevich Solomon Officer: PRESIDENT, CLINICALDIAGNOSTICS
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)432406.9398
175,797.9936

Derived: shares × price per share. Exact value 175797.9936.

103,691Direct (D) Yes
F2, F4
  • F2 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.
  • F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $406.4150 to $407.3750 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0002010019-26-000038 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
FMR LLC COMMON STOCK10.515,131,244.7210/30/2026 Filed 2026-11-06SCHEDULE 13G/AAmendment 1Open filing 0000315066-26-002940 Dispute this row
Abigail P. Johnson COMMON STOCK10.515,131,244.7210/30/2026 Filed 2026-11-06SCHEDULE 13G/AAmendment 1Open filing 0000315066-26-002940 Dispute this row
FMR LLC COMMON STOCK9.513,659,508.2509/30/2026 Filed 2026-11-05SCHEDULE 13GOpen filing 0000315066-26-002810 Dispute this row
Abigail P. Johnson COMMON STOCK9.513,659,508.2509/30/2026 Filed 2026-11-05SCHEDULE 13GOpen filing 0000315066-26-002810 Dispute this row
T. Rowe Price Associates, Inc. COMMON STOCK6.39,021,82506/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 4Open filing 0000080255-26-000548 Dispute this row
Vanguard Capital Management Common Stock5.087,205,93903/31/2026 Filed 2026-04-30SCHEDULE 13GOpen filing 0002100119-26-000780 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 7Open filing 0000102909-26-001882 Dispute this row
T. Rowe Price Associates, Inc. COMMON STOCK7.810,872,70212/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 3Open filing 0000080255-26-000263 Dispute this row
JPMORGAN CHASE CO. Common Stock, par value $0.0001 per share9.112,825,64012/31/2025 Filed 2026-01-23SCHEDULE 13G/AAmendment 2Open filing 0000019617-26-000064 Dispute this row
T. Rowe Price Associates, Inc. COMMON STOCK8.912,191,81406/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 2Open filing 0000080255-25-000584 Dispute this row
JPMORGAN CHASE CO. Common Stock, par value $0.0001 per share7.710,594,25606/30/2025 Filed 2025-07-22SCHEDULE 13G/AAmendment 1Open filing 0000019617-25-000544 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,093,437 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
202240,015
2023199,811
2024186,415
2025235,520
2026254,737

Filings made before the SEC required XML are listed, not extracted.

Back to Natera, Inc.